“an increasing trend”

It should be notable that the PRL of the metformin group showed a decreasing trend (from 1737.360 ± 626.918 to 1618.625 ± 640.865, t = 1.759, P = 0.086), while that of the placebo group showed an increasing trend (from 2676.470 ± 1269.234 to 2860.933 ± 1317.376, t = 1.866, P = 0.069).

However, there was an increasing trend between survey years in the percent of on-campus residents reporting past-30-days DWI/RWID (44.1 vs. 49.9, chi-square = 4.14, df = 1, p = 0.069).

An increasing trend for total antioxidant status (TOS) at the end of the experimental period ( p = 0.069) was observed.

Furthermore, the mRNA and protein levels of anti-inflammatory cytokine IL-10 were markedly downregulated in the CML group relative to the CM group ( P < 0.05), and IL-10 concentration showed an increasing trend in the CMLB group compared to the CML group ( P = 0.069, Fig. 1 H–N).

Compared with Cluster 1, cluster 3 exhibited significantly higher activity scores for “ferroptosis” (adjusted P = 0.025, δ = −0.29), “lipid peroxidation” (adjusted P = 0.025, δ = −0.28), and “glycerolipid metabolism” (adjusted P = 0.028, δ = −0.26), along with an increasing trend for “fatty acid metabolism” (adjusted P = 0.07, δ = −0.22) ( Figure 3E ).

Koulouris et al noticed an increasing trend of recurrent HSI in previous history of HSI (p=0.07) 35 .

Fat mass showed an increasing trend (10.6 [8.9–13.8] → 12.9 [10.8–16.1] kg; +28.7%; p = 0.07; d = –0.74), while BFMI showed minimal change (4.5 [3.4–5.1] → 4.2 [3.1–5.9] kg/m2; p = 0.08; d = –0.22).

In contrast, CLS density showed an increasing trend from 3.2 (SD 2.3) to 4.2 (SD 3.3) in the conservative group ( p = 0.07 for paired t test, Figure 3A ).

The current engagement domain was not statistically significant; however, there was an increasing trend towards engagement and use of self-awareness assessments from pre- to post-session timepoints which was maintained at follow-up ( F (2, 82) = 2.804; p = 0.07).

2 C,M; ** P < 0.01), and an increasing trend was also observed for Kiss1r immunostaining relative to the hypo group (Fig. 2 F,M; P = 0.07).

Dietary 0.25% FBP supplementation displayed an increasing trend ( p = 0.070) in the ileal VH ( Table 3 ).

There was an increasing trend in piglet weight at weaning (BG, p = 0.07), litter weight at the 21st day of lactation (BG, p = 0.07) and litter weight gain (BG, p = 0.08) in groups supplemented with 0.1% β-glucan.

The processing method did not influence calcium or phosphorous balance parameters, except for their urinary losses, which showed an increasing trend (p=0.07).

The risk of MM in genetically predicted AS patients had an increasing trend with marginal statistical effect in the IVW analysis (OR = 1.001; 95% CI, 1.000–1.002; p = 0.07) ( Figures 3 , 4C ).

wild type) in colony frequencies and an increasing trend (average caspofungin resistant colony frequency = 2.17E-7 ± 7.65E-8 and 1.98E10-7 ± 1.04E-7; P = 0.07 and P = 0.06, respectively).

The total number of all amputations shows an increasing trend in the longer term (KWT p=0.07, ρ=0.16, p=0.008), which is due to the significant increase in the number of minor amputations (from 16,143 in 2019 to 17,872 in 2023, KWT p=0.002) by the constant number of major amputations (KWT p=0.4) ( Figure 3B ).

Finally, in Latinx/Hispanic individuals, the AAMR remained stable over the entire study period [AAPC + 1.7% (95%CI -2.0 to 5.5), p = 0.38), despite an increasing trend from 2012 to 2019 [APC: +8.7%, (95%CI: -0.9 to 19.2), p = 0.07) which did not reach statistical significance.

The Simpson index displayed an increasing trend ( p = 0.07) in the CHV group compared with the CON and LYSO groups.

In the subgroup of patients with elevated BMI, the mean glucose value at 120 min showed an increasing trend ( p = 0.07); in patients with normal BMI (<25 kg/m 2 ), the mean glucose value at 120 min was 5.64 ± 1.2 mmol/L, and in patients with elevated BMI (≥25 kg/m 2 ) the value was 6.54 ± 1.66 mmol/L.

In the efficacy group, the LV dimension increased as a function of time as follows: at 4 weeks, Z-scores for MV, AOV, AAO, and isthmus dimensions were significantly greater than those obtained prior to HO therapy (P < 0.01); at 8 weeks, although the MV, AOV, and AAO dimensions demonstrated an increasing trend that did not reach statistical significance (P = 0.07, 0.06, 0.1, respectively), the Z-scores of the isthmus in the three-vessel and trachea view (3VT) views were significantly greater than those obtained at earlier time points (P < 0.05).

The results suggest that it is unlikely that the decrease in NMF levels after SLS and MCI/MI treatment is caused by reduced activity of these enzymes, as their activities showed an opposite trend; protease activities were increased after SLS treatment, and an increasing trend was observed for MCI/MI ( p = 0.07).

However, at pCa 6.0, P1 was unaffected following Myk461 incubations in WT myocardium but showed an increasing trend ( P =0.07) following 1.0 μmol/L Myk461 incubation in KO myocardium (Tables 3 and 4 ).

On the other hand, Parabacteroides was significantly under-represented in RRMS patients ( p = 0.003), who also showed a reduction in [ Ruminococcus ] and Lachnospira ( p ≤ 0.0008), a marked increase in Streptococcus ( p = 0.006), and an increasing trend for [ Eubacterium ] ( p = 0.07).

36 , 42 , 43 In the current study, no significant M1 beta power changes were observed after taking the medication, despite that there was an increasing trend ( p = 0.07).

The expression of the main “longevity” SIRT1 demonstrated an increasing trend in the THC group ( p = 0.07) and unaffected in the CBD group of healthy fibroblasts ( Figure 10 A).